Chemoinformaics analysis of 2-Benzylidenemalonaldehyde
| Molecular Weight | 160.172 | nRot | 3 |
| Heavy Atom Molecular Weight | 152.108 | nRig | 18 |
| Exact Molecular Weight | 160.052 | nRing | 1 |
| Solubility: LogS | -3.603 | nHRing | 0 |
| Solubility: LogP | 3.344 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 23.6383 |
| nHD | 0 | BPOL | 9.76166 |
| QED | 0.672 |
| Synth | 2.358 |
| Natural Product Likeliness | 1.351 |
| NR-PPAR-gamma | 0.964 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.043 |
| Pgp-sub | 0.017 |
| HIA | 0.01 |
| CACO-2 | -4.958 |
| MDCK | 0.0000118 |
| BBB | 0.01 |
| PPB | 0.973429 |
| VDSS | 0.71 |
| FU | 0.0518988 |
| CYP1A2-inh | 0.971 |
| CYP1A2-sub | 0.692 |
| CYP2c19-inh | 0.396 |
| CYP2c19-sub | 0.055 |
| CYP2c9-inh | 0.733 |
| CYP2c9-sub | 0.907 |
| CYP2d6-inh | 0.761 |
| CYP2d6-sub | 0.493 |
| CYP3a4-inh | 0.636 |
| CYP3a4-sub | 0.096 |
| CL | 5.547 |
| T12 | 0.867 |
| hERG | 0.078 |
| Ames | 0.615 |
| ROA | 0.136 |
| SkinSen | 0.682 |
| Carcinogencity | 0.053 |
| EI | 0.911 |
| Respiratory | 0.196 |
| NR-Aromatase | 0.889 |
| Antiviral | No |
| Prediction | 0.863912 |